Vitality Watch

Dossier clinicaltrials trial early 08-jul-2026
Small or early-phase human trial or pilot study

Evaluation of the Effect of a Seaweed Flour- and Leucine-Enriched Food on Metabolic and Inflammatory Status in Older Adults With Probable Sarcopenia or Sarcopenia

Key claim: A clinical protocol will test whether a seaweed flour- and leucine-enriched food improves metabolic-nutritional and inflammatory status, with serum transthyretin as the primary outcome, in older adults with probable sarcopenia or sarcopenia.

Abstract

Sarcopenia and probable sarcopenia are associated with loss of muscle strength, functional impairment, frailty, and an increased risk of adverse outcomes in older adults. In short-term interventions, structural or functional changes may be modest, whereas certain serum biomarkers of metabolic-nutritional response may be more sensitive. In this protocol version, serum transthyretin (TTR) has been selected as the primary outcome, without assuming that it represents, by itself, a direct measure of muscle mass or overall clinical efficacy.

Why this matters

A clinical protocol will test whether a seaweed flour- and leucine-enriched food improves metabolic-nutritional and inflammatory status, with serum transthyretin as the primary outcome, in older adults with probable sarcopenia or sarcopenia.

Source

Link

Briefing card

Evaluation of the Effect of a Seaweed Flour- and Leucine-Enriched Food on Metabolic and Inflammatory Status in Older Adults With Probable Sarcopenia or Sarcopenia
Stage: trial early · clinicaltrials · 08-jul-2026

A clinical protocol will test whether a seaweed flour- and leucine-enriched food improves metabolic-nutritional and inflammatory status, with serum transthyretin as the primary outcome, in older adults with probable sarcopenia or sarcopenia.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: nct:NCT07689994

build build 880 · 2bcef25 · 2026-11-18